Longitudinal study on cardiovascular risk factors in Swiss municipalities
Official title: Swiss Longitudinal Cohort
Run by Hypertension Excellence Centre Lucerne · NCT02282748 · Data updated 2026-11-12
This study looks at heart health and risk factors in people from three Swiss towns to see how they change over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Hypertension Excellence Centre Lucerne Academic / other |
| Locations | 3 sites (Uznach, Canton of St. Gallen and 2 other locations) |
| Status | Recruiting |
| Started | October 2014 |
| Main results expected | September 2024 |
| Study ends | September 2034 |
| Registry record updated | February 18, 2020 |
| Trial ID | NCT02282748 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are residents of Cama GR, Lostallo GR, or Uznach SG, aged 6 years and older.
✕Probably not a fit
Patients who do not reside in the specified municipalities or are unwilling to participate in a long-term study may not benefit from this research.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research project is a prospective population-based cohort study aimed at examining cardiovascular risk factors in three Swiss municipalities. Recruitment began in 2014 in Lostallo/Cama and concluded in 2019, with a total of 496 participants. The study involves a five-year follow-up and plans to start recruitment in a second municipality, Uznach, in 2020. Participants undergo a variety of measurements to gather comprehensive data on cardiovascular health.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into cardiovascular risk factors specific to the Swiss population, potentially leading to improved prevention strategies.
How similar studies have gone: While this study is modeled after the well-known Framingham study, it represents a novel approach in Switzerland as there are no similar research projects currently underway.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Resident of Cama GR, Lostallo GR, or Uznach SG * Age ≥6 years (no upper age limit), for voluntary blood sample ≥18 years * Willing to participate in long-term study * Written informed consent (in participants ≥6 years and \<18 years signed by parents) Exclusion Criteria: * No exclusion criteria
Where it's running
-
Linth Hospital
Uznach, Canton of St. Gallen, Switzerland Recruiting -
Cama
Cama, Kanton Graubünden, Switzerland Recruiting -
Lostallo
Lostallo, Kanton Graubünden, Switzerland Recruiting
Study contacts
- Principal investigator: Andreas W Schoenenberger, MD — University Department of Geriatrics, University of Bern
- Study coordinator: Paul Erne, MD
- Email: paul.erne@erne-net.ch
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Structured management of adult cardiovascular risk factors in outpatient care
This project will try a structured clinic approach to managing blood pressure, cholesterol, diabetes, and weight in adults with cardiovascular risk factors to see if it improves risk control and outcomes.
-
Faster versus controlled weight training after a kidney transplant
This trial will test whether doing resistance exercises quickly versus more slowly for 12 weeks improves kidney health, metabolic markers, and strength in adults who have had a kidney transplant.
-
AI-powered ECG interpretation to detect heart failure in older primary care patients
This trial tests whether the AI tool Willem™ helps primary care doctors detect heart failure from ECGs in people aged 65 and older who have symptoms or are at high cardiovascular risk.
-
Understanding how sleep affects heart health
This study looks at how different aspects of sleep affect heart health and disease risk in people living in Singapore, especially those who may not be getting enough rest.
-
Digital heart-health app and lifestyle program for adults with heart disease or high-risk diabetes
This program will test whether adding a digital heart-health app and lifestyle support to usual care helps adults on statins with established heart disease or high-risk type 2 diabetes lower their cardiovascular risk.
-
Substituting high- with low-ultra-processed soy protein foods within a guideline-based diet for cardiometabolic health
This study tests whether a 12-week digital diet program with extra fruits and vegetables, combined with either low- or high-ultra-processed soy protein foods, can lower systolic blood pressure in adults with hypertension and obesity, about half of whom have type 2 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.